Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.
The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.
Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1794.30 |
| Dr. Reddys Lab | 1275.05 |
| Cipla | 1383.00 |
| Zydus Lifesciences | 1105.65 |
| Lupin | 2274.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: